Ligand validation:4NVF

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NVF_MES_A_301	98%	12%	0.062	0.986	2.14	1.92	1	3	0	0	100%	1
4XV6_MES_A_302	98%	46%	0.063	0.988	0.87	1.2	1	3	0	0	100%	1
4JM5_MES_A_303	97%	12%	0.065	0.983	1.2	2.87	1	7	1	0	100%	0.4
4JQN_MES_A_303	83%	16%	0.103	0.961	1.77	1.92	2	3	4	0	100%	0.3
5U5V_MES_A_303	83%	18%	0.107	0.965	2.03	1.52	1	2	0	0	100%	0.26
4NVJ_MES_B_303	75%	42%	0.115	0.947	0.87	1.38	1	2	0	0	100%	0.35
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.